Who are the key players in Global AI in Bioinformatics Market industry?

The top five key players in the Global AI in Bioinformatics Market are IBM Corporation, Microsoft Corporation, Thermo Fisher Scientific, Illumina Inc., and Deep Genomics. These companies lead in developing advanced AI-powered bioinformatics solutions, enabling large-scale data analysis, precision medicine, drug discovery, and genomic research across the healthcare and life sciences sectors.

What is the Global AI in Bioinformatics Market growth?

The Global AI in Bioinformatics Market has experienced strong growth, with a CAGR of over 35% since 2022. For example, IBM's Watson Health platform has expanded its offerings, propelling further adoption of AI-driven bioinformatics tools worldwide and stimulating investments in health data analytics and research innovation.

Which segment accounted for the largest Global AI in Bioinformatics Market share?

Genomics and precision medicine applications hold the largest share in the Global AI in Bioinformatics Market. AI algorithms help researchers interpret genetic data for disease diagnosis, personalized treatments, and drug development. Companies like Illumina and Deep Genomics extensively use AI technology to accelerate genomic analysis and actionable medical insights.

What are the factors driving the Global AI in Bioinformatics Market?

Key factors driving the market include increasing volumes of biological data, demand for personalized healthcare, and advancements in machine learning methods. For example, Microsoft launched AI-powered platforms for bioinformatics that streamline genetic sequencing and data analysis, meeting industry needs for rapid and accurate bioinformatics solutions.

Which type accounted for the largest Global AI in Bioinformatics Market share?

Machine learning-based solutions account for the largest share in the AI in Bioinformatics Market. These platforms, offered by companies like Thermo Fisher Scientific and IBM, facilitate pattern recognition in complex biological data, enabling predictive modeling, genomics research, and efficient data management for medical and pharmaceutical applications.

Home Healthcare

Global AI in Bioinformatics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: Global AI in Bioinformatics Market
Brand: Bussiness Insights

Global AI in Bioinformatics Market: by Type (Software, Services, Hardware), Application (Genomics, Chemoinformatics & Drug Design, Transcriptomics, Proteomics, Metabolomics, Others), Distribution Channels (Direct Sales, Distributors, Online Sales, Resellers, Marketplace, Others), Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Others), Organization Size (Small, Medium, Large) and By Global â Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 07-04-2026 | Format: PDF | Report ID:21858 | Author: Manisha C

RD TOC Segmentation Research Methodology Request For Free Sample Copy

Global AI in Bioinformatics Market Outlook 2025-2035

The global AI in bioinformatics market is witnessing transformative growth driven by increasing adoption of advanced artificial intelligence technologies in genomics, drug discovery, and other omics applications. AI tools are revolutionizing biological data analysis, accelerating research, and enabling breakthroughs in personalized medicine. Integration of machine learning, deep learning, and data mining, along with expanding cloud solutions, is bolstering market growth across both developed and emerging regions.

Latest Market Dynamics

Key Drivers

Rising demand for personalized medicine and genomics data analysis is propelling market expansion. For instance, Illumina’s AI-empowered genomics platforms have significantly enhanced speed and accuracy of genetic sequencing in 2025.

Integration of cloud-based AI bioinformatics platforms enabling global collaboration. Google’s Verily Life Sciences launched new cloud genomics analytics in June 2024, expanding real-time data access for researchers.
Automated drug discovery gaining traction, as shown by BenevolentAI’s 2025 use of advanced deep learning systems to identify new therapeutic candidates, reducing time-to-market for novel drugs.

Expansion of AI solutions to emerging markets—DNAnexus announced strategic partnerships in South-East Asia during July 2024, tapping into untapped genomic research landscapes.
Collaboration between bioinformatics leaders and AI technology firms, as IBM and Thermo Fisher Scientific announced a co-developed AI-powered platform for multi-omics research in August 2024.

High complexity and heterogeneity of bioinformatics datasets remain a challenge—Agilent Technologies addressed this with improved automated AI data pre-processing tools released in June 2024.
Talent shortage in AI-driven bioinformatics skill sets. Sophia Genetics invested in workforce training programs to mitigate this in late 2024.

Stringent regulatory frameworks slowing AI adoption in sensitive healthcare sectors, as seen in Qiagen’s delayed launch of AI-enabled diagnostic solutions due to EU data compliance in July 2024.
Data privacy and security concerns remain, with Microsoft implementing advanced encryption for its AI bioinformatics cloud platform in September 2024 to address industry apprehension.

In 2025, Software dominates the AI in bioinformatics market by type, encompassing a diverse suite of AI-driven analysis and visualization tools. Services follow as organizations outsource complex integration, training, and support needs. Hardware, including GPUs and AI accelerators, supports the underlying computational demand. The ongoing digital transformation in healthcare and research fuels the reliance on innovative software and hardware combinations, while platforms and specialized tools continue gaining preference for tailored applications.

Genomics accounts for the highest share of AI in bioinformatics applications by 2025, leveraging AI to unlock insights from massive genomic datasets. Chemoinformatics & Drug Design is the second largest segment, fueled by the surge in AI-driven drug discovery initiatives. Transcriptomics rounds out the top three, reflecting growing interest in gene expression studies. The emergence of AI models capable of integrating and interpreting multi-omics data is a significant market growth driver.

The global AI in bioinformatics market revenue is projected to rise substantially from $2,800 million in 2020 to approximately $19,500 million by 2035. The adoption curve accelerates post-2025, with annualized growth seen across all regions and market segments. Robust investments in genomics and personalized medical research, alongside continuous improvements in AI technologies, underpin this upward trajectory.

North America leads the global AI in bioinformatics market in 2025, attributed to robust R&D funding, AI innovation, and presence of leading biotech firms. APAC demonstrates significant growth, propelled by increasing biotech investments and genomics projects in China and India. Europe retains a strong share with a focus on collaborative research and regulatory advancements. These regions are set to shape AI-driven bioinformatics innovation and application throughout the forecast period.

Illumina, Thermo Fisher Scientific, and DNAnexus emerge as the top market players by share in 2025. Illumina’s dominance is linked to its comprehensive bioinformatics software ecosystem, while Thermo Fisher’s robust genomics and AI solutions fuel its substantial presence. DNAnexus stands out for its secure, scalable cloud platform supporting AI-powered research collaborations.

Pharmaceutical companies are the primary buyers of AI in bioinformatics solutions, holding the greatest market share in 2025 due to extensive investment in drug discovery and development. Academic and research institutes also represent a significant share, followed by healthcare providers adopting AI for advanced diagnostics and patient care.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	5800
Regions	North America, Europe, APAC, South America, Middle East, Africa
Segments	By Type (Software, Services, Hardware, Platform, Tools, Others), By Application (Genomics, Chemoinformatics & Drug Design, Transcriptomics, Proteomics, Metabolomics, Others), By Distribution Channels (Direct Sales, Distributors, Online Sales, Resellers, Marketplace, Others), By Technology (Machine Learning, Deep Learning, Natural Language Processing, Computer Vision, Data Mining, Others), By Organization Size (Small, Medium, Large)
Players	Illumina, Thermo Fisher Scientific, IBM, Microsoft, DNAnexus, Sophia Genetics, Biomax Informatics, NVIDIA Corporation, Deep Genomics, BenevolentAI, Google (Verily Life Sciences), Genedata, Qiagen, Agilent Technologies, Seven Bridges Genomics

June 2024: Verily Life Sciences launches an AI-powered cloud genomics platform to facilitate cross-border research collaboration.
July 2024: DNAnexus forges strategic partnerships to expand AI-enabled bioinformatics services in Southeast Asia.
August 2024: IBM and Thermo Fisher Scientific announce a joint AI platform for multi-omics research analytics.
September 2024: Microsoft integrates new security technologies into its AI bioinformatics cloud offering to enhance data privacy.
October 2024: Agilent Technologies unveils automated AI-driven data pre-processing solutions for large-scale genomic research.

About the Author

Manisha C

Lead Industry Analyst

Manisha C is a Lead Industry Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Manisha C brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Manisha C has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

Global AI in Bioinformatics Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Global AI in Bioinformatics Market Outlook 2025-2035

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

Market Share by Type, 2025

Market Share by Application, 2025

Market Revenue (USD Million), 2020–2035

Market YOY Growth (%), 2020–2035

Regional Market Share by Region, 2025

Market Players Share (%), 2025

Market Buyers Share (%), 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports